Structure, function and regulation of p63 and p73

Cell Death and Differentiation

Volumn 6, Issue 12, 1999, Pages 1146-1153

  Levrero, M ^a   De Laurenzi, V ^b   Costanzo, A ^a   Gong, J ^c   Melino, G ^b   Wang, J Y J ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; c Abl; p53; p73

Indexed keywords

DNA; DNA BINDING PROTEIN; ONCOPROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P73; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; DNA DAMAGE; GENE FUNCTION; GENE STRUCTURE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

VERTEBRATA;

EID: 0033368883     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400624     Document Type: Review

References (43)

1. Hollstein M, Sidransky D and Vogelstein CC (1991) p53 mutations in human cancers. Science 253: 49-53
2. Ko LJ and Prives C (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
3. Choisy-Rossi C and Yonish-Rouach E (1998) Apoptosis and the cell cycle: the p53 connection. Cell Death Differ. 5: 129-131
4. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2: 305-316
5. Kaghad M, Bonnet H, Yang A, Creacier L, Biscan JC, Valent A, Minty A, Chalon P, Lellas JM, Dumont X, Ferrara P, McKeon F and Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequentely deleted in neuroblastoma and other human cancers. Cell 90: 809-819
6. De Laurenzi V, Costanzo A, Barcaroli D , Terrinoni A, Falco M, Annicchiarico-Petruzzell M, Levrero M and Melino G (1998) Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 188: 1763-1768
7. De Laurenzi V, Catani MV, Costanzo A, Terrinoni A, Corazzari M, Levrero M, Knight RA and Melino G (1999) Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ. 6: 389-390
8. Ueda Y, Hijikata M, Takagi S, Chiba T, Shimotohno K (1999) New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 18: 4993-4998
9. Zaika Al, Kovalev S, Marchenko ND and Moll UM (1999) Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res. 59: 3257-3263
10. Casciano I, Ponzoni M, Cunsolo C, Tonini G, Romani M (1999) Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma. Cell Death Differ. 6: 391-393
11. Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH (1999) p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274: 18709-18714
12. Di Como CJ, Gaiddon C and Prives C (1999) p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol. 19: 1438-1449
13. Chi S-W, Ayeda A and Arrowsmith CH (1999) Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J. 18: 4438-4445
14. Schultz J, Pointing CP, Hofman K and Bork P (1997) SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 6: 249-253
15. Bork P, Koonin EV (1998) Predicting functions from protein sequences-where are the bottlenecks? Nature Genetics 18: 313-318
16. Takada N, Ozaki T, Ichimiya S, Todo S and Nakagawara A (1999) Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res. 59: 2810-2814
17. Jost CA, Marin MC and Kaelin Jr WG (1997) p73 is a human p53 related protein that can induce apoptosis. Nature 389: 191-194
18. Zhu J, Jiang J, Zhou W, Chen X (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58: 5061-5065
19. Lee CW and La Thangue NB (1999) Promoter specificity and stability control of the p53-related protein p73. Oncogene 18: 44171-44181
20. Gong JG, Costanzo A, Tamg HQ, Melino G, Kaelin WG, Levrero M and Wang JYJ (1999) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806-809
21. Agami R, Blandino G, Oren M, Shaul Y (1999) Interaction of c-Abl and p73a and their collaboration to induce apoptosis. Nature 399: 809-813
22. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R and Kufe D (1999) p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399: 814-817
23. Liu ZG, Baskaran R, Lea-Chou ET, Wood LD, Chen Y, Karin M and Wang JY (1996) Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273-276
24. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB and Wang JY (1997) Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516-519
25. Balint E, Bates S, Vousden KH (1999) Mdm2 binds p73 alpha without targeting degradation. Oncogene 18: 3923-3929
26. Ongkeko WM, Wang XQ, Siu WY, Lau AW, Yamashita K, Harris AL, Cox LS, Poon RY (1999) MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr. Biol. 12: 829-832
27. Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin Jr WG, Oren M, Chen J, Lu H (1999) MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell. Biol. 5, 3257-3266
28. Prives C and Hall PA. (1999) The p53 pathway. J. Pathol. 187: 112-126
29. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D and Kaelin Jr WG (1998) Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol. 18: 6316-6324
30. Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M, El-Deiry WS (1998) p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells Int. J. Oncol. 13: 5-9
31. Dobbelstein M and Roth J (1998) The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J. Gen. Virol. 79: 3079-3083
32. Higashino F, Pipas JM and Shenk T (1998) Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc. Natl. Acad. Sci. USA 95: 15683-15687
33. Steegenga WT, Shvarts A, Riteco N, Bos JL, Jochemsen AG (1999) Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins. Mol. Cell. Biol. 19: 3885-3894
34. Dobner T, Horikoshi N, Rubenwolf S, Shenk T (1996) Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473
35. Tao W and Levine AJ (1999) P19(ARF) stabilizes p53 by blocking nucleocytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96: 6937-6941
36. Zhang Y and Xiong Y (1999) Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 5: 579-591
37. Nimura Y, Mihara M, Ichimiya S, Sakiyama S, Seki N, Ohira M, Nomura N, Fujimori M, Adachi W, Amano J, He M, Ping YM and Nakagawara A (1998) p73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer 78: 437-440
38. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T and Takahashi T (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res. 58, 1380-1383
39. Tsao H, Zhang X, Majewski P and Haluska F (1999) Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer Res. 59: 172-174
40. Ikawa S, Nakagawara A, Ikawa Y (1999) p53 family genes: structural comparison, expression and mutation. Cell Death Differ. 6: 1154-1161
41. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A(1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713
42. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Doetsch V, Andrews NC, Caput D and McKeon F (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718
43. Brodeur GM, Sekhon G and Goldestein MN (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256-2263